- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00028509
Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201
Assessment of Clinical and Neuroradiologic Evidence of Methotrexate Leukoencephalopathy in Children Treated on POG 9605 and 9201
RATIONALE: Assessing the effects of methotrexate on brain function in children may improve the ability to plan treatment and decrease side effects.
PURPOSE: Clinical trial to compare brain function of children who have been previously treated with methotrexate.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
OBJECTIVES:
- Compare the incidence of neuropsychological abnormalities and leukoencephalopathy in children previously treated with methotrexate on protocols POG-9605 versus POG-9201.
OUTLINE: This is a multicenter study.
More than 3 years after completion of therapy, patients undergo 9 different tests to assess intelligence, memory, learning, attention, concentration, processing of information, functioning, and visual-motor integration. Patients also undergo MRI of the head.
PROJECTED ACCRUAL: A total of 30-54 patients previously treated on protocol POG-9201 will be accrued for this study. A total of 60-108 patients previously treated on protocol POG-9605 will be accrued for this study.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Quebec
-
Montreal, Quebec, Canada, H3H 1P3
- Montreal Children's Hospital at McGill University Health Center
-
-
-
-
Arkansas
-
Little Rock, Arkansas, États-Unis, 72205
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
-
-
California
-
Stanford, California, États-Unis, 94305
- Stanford Comprehensive Cancer Center - Stanford
-
-
Florida
-
Miami, Florida, États-Unis, 33136
- University of Miami Sylvester Comprehensive Cancer Center - Miami
-
Miami, Florida, États-Unis, 33155
- Miami Children's Hospital
-
Tampa, Florida, États-Unis, 33607
- St. Joseph's Cancer Institute at St. Joseph's Hospital
-
West Palm Beach, Florida, États-Unis, 33407
- Kaplan Cancer Center at St. Mary's Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, États-Unis, 95813
- Cancer Research Center of Hawaii
-
-
Illinois
-
Chicago, Illinois, États-Unis, 60612
- Rush University Medical Center
-
-
Maine
-
Bangor, Maine, États-Unis, 04401
- CancerCare of Maine at Eastern Maine Medial Center
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02111
- Floating Hospital for Children at Tufts - New England Medical Center
-
-
Michigan
-
Detroit, Michigan, États-Unis, 48201-1379
- Barbara Ann Karmanos Cancer Institute
-
Flint, Michigan, États-Unis, 48503
- Hurley Medical Center
-
Grosse Pointe Woods, Michigan, États-Unis, 48236
- Van Elslander Cancer Center at St. John Hospital and Medical Center
-
-
Mississippi
-
Jackson, Mississippi, États-Unis, 39216-4505
- University of Mississippi Cancer Clinic
-
-
Missouri
-
St. Louis, Missouri, États-Unis, 63110
- Siteman Cancer Center at Barnes-Jewish Hospital
-
-
New Jersey
-
Hackensack, New Jersey, États-Unis, 07601
- Hackensack University Medical Center Cancer Center
-
-
New Mexico
-
Albuquerque, New Mexico, États-Unis, 87131-5636
- University of New Mexico Cancer Research and Treatment Center
-
-
New York
-
Buffalo, New York, États-Unis, 14263-0001
- Roswell Park Cancer Institute
-
-
North Carolina
-
Charlotte, North Carolina, États-Unis, 28232-2861
- Blumenthal Cancer Center at Carolinas Medical Center
-
Winston-Salem, North Carolina, États-Unis, 27157-1096
- Wake Forest University Comprehensive Cancer Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, États-Unis, 73104
- Oklahoma University Cancer Institute
-
-
South Carolina
-
Charleston, South Carolina, États-Unis, 29425
- Hollings Cancer Center at Medical University of South Carolina
-
-
Texas
-
Houston, Texas, États-Unis, 77030-2399
- Baylor University Medical Center - Houston
-
San Antonio, Texas, États-Unis, 78207
- University of Texas Health Science Center at San Antonio
-
-
Wisconsin
-
Milwaukee, Wisconsin, États-Unis, 53226
- Midwest Children's Cancer Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
DISEASE CHARACTERISTICS:
Previously enrolled on POG-9201 or POG-9605
- Good prognosis by NCI risk (9201 and 9605 stratum 1)
- Eligible for the therapeutic study
- Completed therapy by 12/31/2000
- No CNS3 at diagnosis
- No relapsed disease
PATIENT CHARACTERISTICS:
Age:
- 1 to 9 at diagnosis
Performance status:
- Not specified
Life expectancy:
- Not specified
Hematopoietic:
- Not specified
Hepatic:
- Not specified
Renal:
- Not specified
Other:
- No Down syndrome
PRIOR CONCURRENT THERAPY:
Biologic therapy
- Not specified
Chemotherapy
- Not specified
Endocrine therapy
- Not specified
Radiotherapy
- Not specified
Surgery
- Not specified
Other
- See Disease Characteristics
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: Cohorte
- Perspectives temporelles: Rétrospective
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Percentage of patients with severe intelligence deficit as evidenced by either a verbal or performance IQ below 85
Délai: Length of study
|
Length of study
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Compare the groups for descriptive purposes
Délai: Length of study
|
Quantitative scales: IQ (WISC III or WPPSI-R, depending on the age of the child), Wide Range Assessment of Memory and Learning (4 subscales), Conner's Continuous Performance Test (Attention/Concentration), Woodcock Johnson Revised Processing Speed Cluster, NEPSP Tower Tests (Executive Functioning), and VSI (Visual-Motor Integration).
|
Length of study
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chaise d'étude: Patricia K. Duffner, MD, Women & Children's Hospital of Buffalo
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- ACCL0131
- COG-ACCL0131 (Autre identifiant: Children's Oncology Group)
- NCI-P01-0198
- CDR0000069100 (Autre identifiant: Clinical Trials.gov)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur gestion des complications thérapeutiques
-
Vyaire MedicalPas encore de recrutementSyndrome d'insuffisance respiratoire du nouveau-néItalie
-
Kristen GanjooRecrutementLéiomyosarcome utérin | LMS - LéiomyosarcomeÉtats-Unis